Screener
Zevra Therapeutics, Inc. ZVRA Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001434647-26-000068
FAQ
- What is Zevra Therapeutics, Inc.'s other non-current liabilities?
- Zevra Therapeutics, Inc. (ZVRA) reported other non-current liabilities of $2.09M in Q2 2026.
- How has Zevra Therapeutics, Inc.'s other non-current liabilities changed year-over-year?
- Zevra Therapeutics, Inc.'s other non-current liabilities decreased by 37.1% year-over-year, from $3.32M to $2.09M.
- What is the long-term trend for Zevra Therapeutics, Inc.'s other non-current liabilities?
- Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s other non-current liabilities has grown at a 63.9% compound annual growth rate (CAGR), from $145K to $1.71M.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.
Ask your AI about Zevra Therapeutics, Inc.'s other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude